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INTRODUCTION
The genus Neisseria has more than 20 species of Gram-negative bacteria that colonize mucosal surfaces and the oral cavity of humans and many animals (Liu, Tang and Exley 2015) . The upper respiratory tract is the most common anatomical site from which Neisseria have been cultured (Barrett and Sneath 1994) . Historically, 16S rRNA cloning experiments have found Neisseria species to be very abundant in the oral cavity (Aas et al. 2005; Paster et al. 2006; Dewhirst et al. 2010) . Metagenomic studies frequently identify sites with >1% abundance for Neisseria (Liu et al. 2012; Ramakrishnan et al. 2017) . Table 1 lists examples of anatomical sites in healthy upper respiratory tracts where Neisseria species have been detected. Table 2 lists infections or other health conditions of the upper respiratory tract where Neisseria species have been detected.
The best studied members of the genus Neisseria are the human pathogenic species Neisseria gonorrhoeae (Ngo) and Neisseria meningitidis (Nme). Ngo is a human specific pathogen estimated to cause >800 000 cases of gonorrhea in the USA each year (Centers for Disease Control and Prevention 2015) . Globally, 106 million individuals are infected annually (WHO 2012) . There is currently no vaccine for the gonococcus. Nme is an obligate human commensal that is capable of causing invasive diseases including sepsis and meningitis. Annually, up to 1200 cases of Ramakrishnan et al. (2017) Neisseria weaveri Oral cavity, sputum Cheek abscess Culture Andersen et al. (1993) meningococcal disease occur in the USA (Cohn et al. 2013) . During 2014, 19 African countries suspected almost 12 000 cases with 1146 deaths (WHO 2015) . Molecular mimicry, antigenic variability and modulation of expression levels of phase-variable genes make it very difficult to design universal vaccines for the pathogenic Neisseria. Both Ngo and Nme can colonize the pharynx asymptomatically. This allows Nme and Ngo to cohabit niches inhabited by commensal species. Species of the genus Neisseria are naturally competent, a trait that permits DNA uptake and horizontal gene transfer (HGT). Commensal Neisseria species are reservoirs from which Ngo and Nme can acquire determinants of antimicrobial resistance (AMR). For example, an Nme strain responsible for a meningitis outbreak in the midwest appears to have acquired its ciprofloxacin-resistant gyrA allele from a commensal Neisseria lactamica prevalent in the community (Wu et al. 2009 ). Cephalosporin resistance of some Ngo strains is due to mosaic penA alleles of commensal origin (Spratt et al. 1992; Ito et al. 2005; Ozaki et al. 2008) .
Recently, a high-level ceftriaxone-resistant gonococcal strain (H041) was isolated from the pharynx (Ohnishi et al. 2011) . Pharyngeal gonorrhea is problematic because it is frequently asymptomatic and therefore hard to eradicate. Pharyngeal carriage strains can disseminate AMR and promote disease transmission. Carriage of Nme is more prevalent in crowded or closed populations (see references in Stephens, Greenwood and Brandtzaeg 2007) . Pharyngeal carriage of both Nme and Ngo can reach significant levels in men who have sex with men (Janier et al. 2003) .
Numerous commensal Neisseria species asymptomatically colonize oral and nasal cavity sites and are only rarely associated with disease. Shotgun metagenome sequencing has shown that commensal species have tropism for different sites in the oral cavity and oropharynx (Donati et al. 2016) . Neisseria subflava is enriched on the dorsal surface of the tongue while Neisseria mucosa is prevalent in gingival plaque and on buccal mucosa (Donati et al. 2016) . As an aside, Bennett et al. have demonstrated with multilocus sequence typing that N. subflava and N. flavescens are phylogenetically the same species. Similar data justify the reclassification of both N. sicca and N. macacae as N. mucosa (Bennett et al. 2012) .
The extent to which commensal Neisseria species host interactions are cooperative or parasitic is unknown. Commensals are believed to compete for niches with pathogens and thus provide protection from colonization and invasion. For example, N. lactamica can displace Nme from the nasopharynx and hinder Nme acquisition (Deasy et al. 2015) . Another example is that N. cinerea infection of bronchial epithelial cells can impede subsequent respiratory syncytial virus infection (Hartwig et al. 2016) . Neisseria species of the tongue are hypothesized to be part of the nitrate-reducing microbiota capable of making nitrite and nitric oxide bioavailable to the human host (Hyde et al. 2014) .
To what extent commensal Neisseria of humans and animals have tropism for their respective hosts is largely unknown. There are hints that cross species tropisms exist. For example, humans and macaques can each be colonized by N. mucosa (called N. macacae in macaques) (Veron, Thibault and Second 1959; Vedros, Hoke and Chun 1983; Weyand et al. 2013) . Neisseria mucosa has been cultured or identified in dogs, cats, ducks, the woodlouse, water and sediment (reviewed in Liu, Tang and Exley 2015) . Thus, this species appears capable of colonizing a broad range of hosts in addition to the environment. Whether N. mucosa exhibits host tropism has not yet been tested. Animal isolates can rarely act as zoonotic pathogens and cause disease in humans (Heydecke et al. 2013) . Neisseria weaveri, an upper respiratory tract commensal found in healthy dogs, has been found capable of causing human infections that include bite wounds (Holmes et al. 1993) , lower respiratory tract infections (Panagea et al. 2002) and septicemia (Carlson et al. 1997) . Neisseria zoodegmatis and N. animaloris, commensals of dogs and cats, have also been found associated with human infections including bite wounds (Vandamme et al. 2006) , periodontitis (van Winkelhoff et al. 2016) and otitis media (Roebuck and Morris 1999) .
THE UPPER RESPIRATORY TRACT

Anatomy
The human upper respiratory tract includes the nose, nasal and oral cavities, pharynx, larynx and trachea. In humans, air is respired through both nasal and oral cavities. Thus, both cavities can be reservoirs for respiratory pathogens. Nasal cavities have multiple functions in addition to olfaction that include filtering, warming and humidifying inhaled air or absorbing moisture from exhaled air. Air respired through anterior nares enters two cavities divided by a septum. Three turbinates project from lateral walls of the nasal cavity: inferior, middle and superior (Harkema, Carey and Wagner 2006) . Ciliated respiratory epithelium accounts for much of the non-olfactory nasal epithelium found in nasal cavities and the nasopharynx of humans and animals (Harkema, Carey and Wagner 2006) . Olfactory epithelium is located dorsally. Much of the nasal mucosa is coated with a layer of mucus that helps filter and trap particles including pathogens. An anterior to posterior flow of mucus powered by ciliary beating moves the mucus layer to the back of the nasal cavity, through the nasopharynx to the oropharynx where it is swallowed into the esophagus for disposal in the digestive tract. The nasal cavity can secrete 20-40 ml of mucus per day (Jones 2001) . Mucus flow provides an innate protective barrier that also serves to deliver antigenic material to lymphoid tissues in the nasal cavity. Nose-associated lymphoid tissue (NALT) can be found in the lamina propria of the human nasal mucosa and disseminated on nasal turbinates (Pabst 2015) . Another location of prominent lymphoid tissue in the pharynx in humans and non-human primates (NHPs) is Waldeyer's ring which consists of pharyngeal, tubal, palatine and lingual tonsils.
Within the nasal cavity, there are several ostia or openings to passages that lead to sinus cavities, tear ducts and the middle ear cavities. Ascending respiratory infections can impact these sites. Many paranasal sinuses flank the nasal cavities. The largest sinus cavities in humans are the maxillary sinuses located ventral to the orbits. Laboratory mice and macaques have maxillary sinuses but not other sinus cavities found in humans including frontal, ethmoid and sphenoid sinuses named by their associations with bones of the skull (Harkema, Wagner and Carey 2010) . Maxillary sinuses are well developed at birth but continue to grow until age 12 by which time ethmoid sinuses have also reached adult size; frontal and splenoid sinuses can grow into the late teens (Gizurarson 2012) . Whether the ageassociated size differences of sinuses impacts neisserial colonization in nasal cavities is unknown. Sinus cavities are lined with ciliated respiratory epithelium and have mucus-secreting cells. Many sinuses drain to the middle turbinate meatus; tear ducts drain to the inferior turbinate meatus (Gizurarson 2012) .
Environmental niches
Readers are referred to a recent review that summarizes many of the environmental stimuli Neisseria species experience in the nasopharynx and molecular mechanisms that contribute to persistence (Laver, Hughes and Read 2015) . Neisseria species inhabiting the respiratory tract must overcome several barriers to persist in this niche. Fluid environments bacteria encounter include nasal secretions and saliva. Nasal secretions arise from many sources including anterior nasal glands, seromucous and submucosal glands, goblet cells, tear fluid and serous and mucus secretion from epithelial cells (Beule 2010) . Mucus is largely made of water and glycoproteins, has a pH of 5.5 to 6.5, anti-oxidant properties and innate antimicrobial activity (Cross, Halliwell and Allen 1984; Cole, Dewan and Ganz 1999; Beule 2010) . Antimicrobial components of mucus include lysozyme, lactoferrin, secretory leukoprotease inhibitor, uric acid, peroxidases, surfactants, aminopeptidases, immunoglobulins, neutral endopeptidases, phospholipases and defensins (Cole, Dewan and Ganz 1999) . The antimicrobial activity of nasal secretions can drop in patients with respiratory infections such as chronic rhinosinusitis (Woods et al. 2015) . Humidity and temperature extremes can negatively impact ciliary activity and proper mucus flow (Williams et al. 1996) .
Serum components, including complement proteins, can be found in nasal mucus and tissues (Casado et al. 2005; Lane et al. 2006) . Many serum proteins can move into nasal secretions via transudation. The levels of serum proteins in nasal secretions rise during inflammation. This is likely due to increases in vascular permeability (Baumgarten et al. 1985; Casado et al. 2004) .
Nitric oxide (NO) is produced in the nasal cavity and paranasal sinuses (Haight et al. 1999) . NO has antibacterial activity and regulates ciliary beating that is essential for mucociliary clearance (Hoehn et al. 1998; Kim et al. 2001) . NO can combine with various radicals to produce reactive oxygen and nitrogen intermediates capable of damaging components of bacterial cells.
There are many undefined stimuli that lead to variation in the abundance of Neisseria species in the human upper respiratory tract. During pregnancy, the rise of sex hormones correlates with variations in the levels of microorganisms in subgingival plaque (Adriaens et al. 2009; Kumar 2013) . Postpartum, when sex hormone levels drop, Neisseria mucosa abundance was found to increase (Adriaens et al. 2009 ). In vitro, progesterone can have bacteriostatic and bactericidal effects on Ngo (Morse and Fitzgerald 1974) . Progesterone was also found to significantly retard growth of Nme and N. flavescens but not N. mucosa. Progesterone and estrogen levels correlate with increased vascular permeability and bleeding upon periodontal probing (Miyazaki et al. 1991) . These conditions could contribute to an increase in killing by serum components such as complement. Disease states which lower salivary abundance of N. mucosa and N. elongata include inflammatory bowel disease (IBD) and pancreatic cancer, respectively (Farrell et al. 2012; Said et al. 2014 ). In the case of IBD, the drop in neisserial abundance correlated with an increase in salivary cytokine concentrations.
Ethanol use can increase the abundance of Neisseria species on the tongue, likely due to high neisserial alcohol dehydrogenase levels capable of oxidizing alcohol (Muto et al. 2000) . Another metabolic capability of Neisseria species that likely contributes to their abundance in the upper respiratory tract is the use of propionic acid as a growth substrate. Propionic acid-producing bacteria are prevalent in the oral cavity. Nme encodes enzymes for a methylcitrate cycle that catabolizes propionate (Catenazzi et al. 2014) . The authors speculate that the enzyme encoding locus was acquired by HGT from distantly related commensal Neisseria species such as N. mucosa and N. subflava. Neisseria species associate with propionic acid-producing Corynbacterium and Actinomyces in supragingival dental plaque (Mark Welch et al. 2016) . As more is learned about the interactions of the genus Neisseria with other micoorganisms and the human host, more will be learned about specific niches of the respiratory tract. Neisseria subflava is a necessary helper strain for in vitro growth of some strains of Group A streptococci (Johnson et al. 1989b ). Knowledge about the metabolites consumed or excreted by Neisseria species will help elucidate preferred niches in the human body. For example, lactate utilization permits survival in nasopharyngeal tissue in addition to other cell types Atack et al. 2014) . Pyrophosphate utilization by Nme is hypothesized to allow iron acquisition from lactoferrin in the nasopharynx (Biville et al. 2014) . For further information about Nme metabolism and virulence, see Schoen et al. (2014) .
ANIMAL MODELS
This review will primarily focus on animal models with intranasal or oral inoculation routes. The exquisite tropism of neisserial pathogens for the human host has hampered the development of infection and persistence models that completely mimic human infections. The models reviewed below are being used to study molecular determinants of Neisseria-host interactions, innate and adaptive immune responses, vaccine efficacy against carriage, phase variation, immune evasion and HGT of AMR. Table 3 summarizes several examples of Neisseria infection and persistence models of the upper respiratory tract in mice, NHPs and human volunteers.
Murine models
Much of our knowledge regarding neisserial virulence is based on tissue and organ culture systems (Stephens 1989; Trivedi, Tang and Exley 2011) . Nme and Ngo do not naturally infect animals; inoculated into non-human hosts, they will colonize only for brief periods. Mice are resistant to Ngo colonization when the genital tract is inoculated (Johnson et al. 1989a) . Antibiotic and estradiol treatments can overcome natural resistance to Ngo vaginal colonization (Jerse et al. 2011) . Whether these combined treatments overcome barriers to respiratory tract colonization is unknown. Many attempts have been made to develop mouse models that mimic early stages of human meningococcal infections. Models that study mucosal infection routes, such as intranasal or oral inoculation, are desired because they mimic natural exposures and can be used to study host-bacterial interactions in upper respiratory tract niches. Intranasal inoculation models have demonstrated a requirement for capsule and lipooligosaccharide (LOS) for Nme carriage but have been limited by a dependence on high-dose inocula, iron source supplementation and infant mice (Salit, Van Melle and Tomalty 1984; Mackinnon et al. 1993) . Some models of intranasal inoculation result in pneumonia prior to bacteremia and thus do not mimic progression of meningococcal disease in humans (Mackinnon et al. 1992; Gorringe et al. 2001 ). Sequential infections with influenza A virus and Nme lead to capsule-dependent sepsis and lung infection (Alonso et al. 2003) . Influenza A virus neuraminidase appears to modify Nme capsule in such a way that enhances Nme adhesion (Rameix-Welti et al. 2009 ). Adult mice can support nasal colonization for almost 2 weeks if they are given daily injections of iron (Yi, Stephens and Stojiljkovic 2003) . Colonization in this model can be hindered by mutations that truncate LOS or disrupt PilQ and capsule expression. Complement hinders nasal colonization as mutant strains with truncated LOS or lacking capsule persisted better in complement-deficient mice. Immunoglobulin A (IgA) was detected in nasal washes but not serum of mice colonized over 13 days (Yi, Stephens and Stojiljkovic 2003) . While the pharyngeal models described above are valuable, concerns remain regarding reproducibility, requirements for iron supplementation, length of persistence and the specificity of host-bacterial interactions.
Transgenic mice (Tg) provide the opportunity to focus on specific receptors and their cognate bacterial ligands. In the context of knock-in Tg mice, this allows simplification and the avoidance of multifactorial interactions that participate in humanNeisseria interactions. Below, three transgenic models being utilized to study upper respiratory tract infection and persistence are discussed. Care should be taken in directly comparing the results of the models that follow because sampling variations may impact reproducibility of both bacterial load and carriage duration. Protocols that rely solely on lavage may better quantify non-adherent bacteria while tissue sampling approaches may better quantify adherent bacteria.
CEACAM1
The Gray-Owen laboratory has utilized human CEACAM1 transgenic mice to study asymptomatic carriage of Nme. CEACAMs (carcinoembryonic antigen-related cell adhesion molecules) are 
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members of a subfamily of immunoglobulin-related proteins capable of interacting with neisserial Opa adhesins (Tchoupa, Schuhmacher and Hauck 2014) . CEACAM1 mice allow carriage of Opa adhesin-expressing Nme up to 10 days post-inoculation (Johswich et al. 2013) . Nme recovery was chiefly evaluated 3 days after inoculation. Non-transgenic mice colonization fails to persist beyond 1 day after inoculation. For one set of experiments, the Nme inoculum was negative for Opa expression. However, recovered Nme were Opa+; thus, this model can select for Opa expressing phase variants in the nasal cavity. Innate immune defenses were studied by depleting polymorphonuclear cells (PMN) and/or activating the complement cascade. PMN depletion prolonged recovery of Nme to 14 and 3 days for CEACAM1 and non-trangenic mice, respectively. Cobra venom factor (CVF) treatment, in this model, reduced C3 serum levels at 4 h to 6 days post-administration (see supplementary data in Johswich et al. 2013) . CVF treatment in combination with PMN depletion significantly increased the Nme burden in CEACAM1 mice demonstrating that these arms of innate immunity work synergistically to impede nasal colonization. The CEACAM1 mouse nasal inoculation model allows study of protective adaptive immune responses. Prolonged colonization mediated by successive intranasal inoculation at days 0 and 21 significantly reduced colonization upon challenge at day 52 with viable serogroup B Nme strain H44/76 (Johswich et al. 2013) . Sterilizing immunity was associated with localized IgA secretion in the upper respiratory tract but not IgG. CEACAM1-dependent dissemination to submucosal sites in the nasal cavity likely contributes to localized IgA secretion. Sterilizing immunity against serogroup C Nme strain 90/18311 was achieved by subcutaneous injection with a serogroup C polysaccharide conjugate vaccine. Immunity to nasal colonization by subcutaneous vaccination correlated with an increase of nasal and serum IgG but not IgA (Johswich et al. 2013) .
In mice, the NALT is a site of IgA and IgG production (Fernandez et al. 2011) . Murine NALT is located at the base of the nasal ducts, whereas in humans it is disseminated on nasal concha (Pabst 2015) . The contribution of NALT to sterilizing immunity against Nme in CEACAM1 transgenic mice remains unknown. NALT was dispensable for vaccine-induced protection from pneumococcal colonization of the mouse nasopharynx whereas cervical lymph nodes played a role (Sabirov and Metzger 2008) . In contrast, NALT did contribute to nasal immunity against toxic shock syndrome by Staphylococcus aureus (Fernandez et al. 2011 ).
The CEACAM1 model has allowed an assessment of crossprotection by closely related and disparate Nme strains . Nasal carriage of Nme promoted sterilizing immunity against closely related strains. Notably, antibody cross-reactivity measured by serum bactericidal assays was not a reliable predictor of whether nasal inoculation with one strain would protect against carriage of a heterologous strain. For future studies, Johswich et al. plan to determine if T cells can contribute to sterilizing immunity in this model. Pajon et al. used the CEACAM1 mouse model to show that outer membrane vesicle vaccines can protect from nasotracheal colonization when protein antigens match the challenge strain (Pajon et al. 2015) . Passive protection against carriage can also be achieved with serum from vaccinated CEACAM1 mice (Pajon et al. 2015) .
The CEACAM1 mouse is a natural exposure model useful for studying immune responses initiated by intranasal colonization. Persistence in CEACAM1 mice is short-term unlike Nme carriage in humans which can persist for weeks, months or over a year (De Wals et al. 1983; Caugant et al. 2006; Glitza et al. 2008) . Nor does the model lead to invasive disease. These deficiencies may be abrogated by increasing the complexity of the model with additional transgenes for human forms of factor H and or transferrin. Regardless, the model will continue to help evaluate the impact of specific vaccine antigens, vaccine formulations and vaccine delivery methods on nasopharyngeal carriage. It will be interesting to see what new insights the model will provide concerning mucosal immune mechanisms in the upper respiratory tract.
CD46
Mice expressing human CD46 were used for the study of Nme infection in 2003 (Johansson et al. 2003) . CD46 is one of several proteins hypothesized to interact with type IV pili (Tfp) of pathogenic Neisseria species (Kallstrom et al. 1997; Blom et al. 2001; Edwards et al. 2001; Edwards and Apicella 2005; Bernard et al. 2014; Coureuil et al. 2014 ). CD46's role in neisserial adhesion remains uncertain because CD46-independent adhesion by Tfp is possible (Kirchner, Heuer and Meyer 2005) . Regardless, intranasal inoculations of CD46 transgenic mice result in mortality when mice are treated with antibiotics, highlighting a protective role of commensal bacterial flora (Johansson et al. 2003) . The mortality rate achievable by this model was only 15%. One explanation provided by the authors is that CD46 expression in the trachea was exclusively basolateral. Intraperitoneal (i.p.) and intervenous (i.v.) injections result in high mortality rates in CD46 mice but not in non-transgenic animals. The systemic disease induced by i.p./i.v. challenge of CD46 transgenic mice is not the focus of this review. However, it is noteworthy that i.v. inoculated Nme can disseminate from blood to the respiratory tract within 24 h in a PilC1 adhesin-dependent manner (Sjolinder and Jonsson 2007) . Nme were recovered from nasal washes 3 days post-i.v. inoculation, but not earlier, and expressed Opa adhesins indicative of phase variation (Sjolinder and Jonsson 2007) .
Opa phase variants were detected in both the CEACAM1 and CD46 transgenic models. Selection pressures for Opa switching in the two models are likely very different. Opa-CEACAM1 interactions likely drive adhesion of Opa+ bacteria in the nasal cavity. The CEACAM1 model is an asymptomatic carriage model, whereas the CD46 model can lead to damage of epithelial tissues (Sjolinder and Jonsson 2010) . It could be that nasal cavity tissue damage exposes bacteria to more serum in CD46 Tg mice. Complement cascade activity may be higher in CD46 Tg mice as they express higher serum levels of the complement protein C5a, an anaphylatoxin (Johansson et al. 2005) . Inflammation or serum leakage could expose Nme to complement killing. Transit through the blood stream may also select for Opa expression in vivo as human serum has been shown to select for serumprotective Opa expression in vitro (Bos, Hogan and Belland 1997) .
Following intranasal inoculation of CD46 mice, damage and thinning of olfactory epithelium is apparent at 3 days postinoculation. Nme was found to disseminate to the basal membrane, lamina propria, cribriform plate and the olfactory bulb of transgenic mice (Sjolinder and Jonsson 2010) . NhhA, a meningococcal surface autotransporter adhesin, is required for nasal cavity adhesion in CD46 mice (Sjolinder et al. 2008) . In vitro, strains devoid of NhhA are more susceptible to phagocytosis and complement killing (Sjolinder et al. 2008; Griffiths et al. 2011) . Intranasal application of recombinant NhhA to CD46 mice promotes increased Nme nasopharyngeal colonization and a drop in local levels of proinflammatory cytokine IL-6 (Wang et al. 2016 ). NhhA treatment reduced the level of Nme-induced mucosal damage and was associated with less leukocyte infiltration. NhhA was found to promote differentiation of monocytes into macrophages that have a diminished capability of secreting proinflammatory cytokines in response to Nme. These findings support the hypothesis that NhhA modifies immune host responses in a way that promotes asymptomatic colonization of the nasal mucosa.
Transferrin
The Taha laboratory has used Tg mice expressing human transferrin to study meningococcal disease (Zarantonelli et al. 2007) . Invasive disease results from either i.p. or intranasal inoculation and does not require additional iron supplementation. Following high-dose intranasal inoculation, Nme persisted better in the lung and blood of Tg mice than in non-transgenic animals. While i.p. challenge resulted in crossing of the blood-brain barrier, intranasal inoculation did not. Intranasal inoculations promote disease in this model 7 days after intranasal infection with a sublethal dose of influenza A (Zarantonelli et al. 2007 ). The bacteria load in the nasal cavity was not reported. Transferrin Tg mice are primarily being used to model invasive disease after i.p. injections. It would be interesting to know the impact of human transferrin on the levels of nasal cavity colonization that results from both i.p. and intranasal inoculation routes.
Neisseria musculi
One means of circumventing host restriction of human-specific pathogens is to develop animal models of infection using related species indigenous to that animal. For example, infections of human-restricted pathogens such as Chlamydia trachomatis have been effectively modeled in animals with C. muridarum (Miyairi, Ramsey and Patton 2010) . Such approaches can also be used to model asymptomatic carriage by pathogenic and commensal Neisseria species. Recently, a new species in the genus, N. musculi, was identified in the oral cavities of healthy wild-caught house mice. This organism was characterized by multilocus sequence typing and found to be closely related to the cow commensal N. dentiae (Weyand et al. 2016) . Neisseria musculi shares gene content with the genus, including Tfp biogeneisis genes and over 3000 copies of the DNA uptake sequence (DUS). Neisseria musculi is naturally competent and depends on the Tfp retraction motor protein PilT and the DUS for DNA transformation (Weyand et al. 2016) . Our preliminary experiments found that N. musculi could colonize mice for over 1 year following oral inoculation (unpublished observations, Ma, Powell, Weyand, Frelinger and So) . Moreover, a N. musculi pilE mutant was defective in colonizing mice, demonstrating the promise of this model in studying Neisseria-host interactions. The long-term persistence of N. musculi is a clear advantage this model has relative to other murine models of carriage. Neisseria musculi has likely co-evolved with its host. Future studies will allow the study of many orthologs of virulence and host-association determinants shared with Nme, Ngo and commensal species of the genus. The interaction of N. musculi ligands with the native host's receptors is predicted to trigger intact murine signaling pathways. On the other hand, Tg mouse models expressing a single human transgene may not have fully conserved signaling pathways. For example, the cytoplasmic tails of human CD46 are not conserved in the murine CD46 ortholog (Tsujimura et al. 1998) .
Mouse models are relatively inexpensive, have many cell and molecular biology reagents and allow assessment of host genetic contributions to infection. It is not known to what extent observations made in rodent models will translate to mechanisms of carriage and pathophysiology in humans. A recent large-scale study demonstrated that murine infection models poorly mimic human inflammatory disease (Seok et al. 2013) . Some anatomical differences of the murine respiratory tract are worth noting. First, mice have complex folding and branching turbinates whereas humans and NHPs have simple scrolls. These differences lead to differences in airflow and point to a greater need in mice for olfactory function. The complex turbinates of mice also lead to better filtration and absorption (Harkema, Carey and Wagner 2006) . Second, the olfactory epithelium extends over a greater percentage of the nasal cavity in rodents than in humans or monkeys (Harkema, Carey and Wagner 2006) . Third, mice are obligate nose breathers because of the closeness of the epiglottis to the soft palate (Harkema, Carey and Wagner 2006) . Despite the differences mentioned above, mouse models will continue to be invaluable in elucidating bacterial and host molecular determinants that contribute to infectious disease and asymptomatic carriage.
NHP models
NHPs can provide important models because of their close evolutionary, physiological and behavioral relatedness to humans. NHP studies may have more translational relevance than murine models but host responses may be more variable because the animals are outbred.
Nme and N. lactamica can be cultured from chimpanzee throat swabs (Brown, Kraus and Arko 1973; Kraus, Brown and Arko 1975) . Studies with chimpanzees showed that Ngo can colonize the pharynx (Kraus, Brown and Arko 1975; Arko et al. 1976 ). Chimp models are not practical due to the high cost and low availability of animals, ethical issues and the endangered status of chimpanzees. Unfortunately, inoculation of monkey hosts such as baboons and crab eating macaques with human pathogenic Neisseria does not result in persistent pharyngeal colonization (DiGiacomo et al. 1977; Bowie et al. 1978) .
Neisseria macacae, isolated in 1983, is found in rhesus macaques (RMs) (Vedros, Hoke and Chun 1983) . We reported that the N. macacae genome encodes closely related orthologs of many factors hypothesized or demonstrated to play a role in Ngo or Nme virulence (Weyand et al. 2013) . These include proteins involved in Tfp biogenesis. Neisseria macacae also contains genes encoding components of current Nme vaccines such as fHbp, GNA1030, GNA2091, NadA and Porin P1, and promising vaccine antigens such as LctP (Sun et al. 2005) . These findings suggest that N. macacae and other Neisseria species indigenous to RMs could prove useful for modeling Neisseria-host interactions in macaques.
RMs are frequently used to model human disease. Macaques are being used to test responses to the serogroup B vaccine MenB-4C (Giuntini, Beernink and Granoff 2015) . As mentioned above, NHPs share very similar turbinate structures with humans. While three turbinates are found in humans, RMs have two: ethmoturbinates and maxilloturbinates (Harkema, Carey and Wagner 2006) . Another difference is that RMs have nasopalatine ducts that allow anterior nasal clearance into the roof of the mouth (Wolff et al. 1993) .
We reported that RM Neisseria recolonize RMs after laboratory passage (Weyand et al. 2013) . After treating two macques with enrofloxacin to remove the pre-existing Neisseria microbiota, antibiotic-resistant derivatives of three distinct RM Neisseria strains were inoculated into two RMs. Two animals were similarly treated with enrofloxacin but not inoculated to serve as negative controls. At this stage of the experiment, each animal was separately housed. One animal was orally and nasally inoculated with two distinct rifampicin-resistant (RifR) Neisseria strains: one on day 0 and the other on day 7 (Fig. 1A) . A second animal was inoculated with the same streptomycin-resistant (SmR) strain on days 0 and 7. Very few of the Neisseria strains were cultured from tongue and throat swabs during the first week post inoculation (p.i.). However, by day 14 p.i. robust colonization was detected. Recovered Neisseria isolates were genotyped by sequencing the gdh gene to establish that their genotypes matched the inoculation strains. The two negative control animals were housed in the same room as the experimental cohort and monitored as a control for aerosol transmission from Neisseria inoculated animals. Transmission was not detected, as the inoculated Neisseria strains were never detected in the negative control RMs.
After colonization of the inoculation strains was detected, the RMs were placed into paired housing on day 17 p.i. By day 28 p.i., both animals were colonized with two Neisseria strains, each singly resistant (RifR or SmR, but not both). This indicates that strain transmission had occurred in less than 14 days after pairing (Fig. 1B) . RMs enrolled in the inoculation studies were grooming pairs. Transmission of Neisseria strains between animals housed together was therefore likely the result of direct contact.
The pre-existing Neisseria strains of the inoculated animals were never cultured again indicating that the strains were effectively cleared by enrofloxacin treatment or displaced by the inoculation strains. In contrast, several of the pre-existing strains detected in the negative control RMs were retrieved at later time points. Our preliminary data support the hypothesis that the enrofloxacin treatment failed to clear these strains because they are more resistant to enrofloxacin (manuscript in preparation, Weyand et al.) . Near the end of the experiment, Neisseria isolates resistant to both rifampicin and streptomycin were cultured from both inoculated macaques. Genotyping numerous loci allowed a determination of the donor and recipient strains. The results were consistent with in vivo HGT (Fig. 1B) .
Little is known about how Neisseria species colonize nasopharyngeal sites and persist in the face of host mucocillary clearance mechanisms. Mucociliary clearance from macaque nasal turbinates is very similar to humans (Wolff et al. 1993) . On the last day of the experiment, day 72 p.i, the animals were cultured for Neisseria at numerous respiratory sites (Weyand et al. 2013) . Strains naturally transmitted between cage mates had migrated to uninoculated sites high in the nasal cavity, areas thick with mucous and difficult for bacteria to penetrate. These sites included the epithelia covering the cribriform plate, ethmoturbinates, maxilloturbinates and nasopharynx above the soft palate (Fig. 1C) . The fact that RM Neisseria can transit to distal nasal cavity sites following transmission mimics the ability of Ngo to cause ascending infections in the female reproductive tract in humans and mice (Hook and Holmes 1985; Jerse 1999) ; and Nme to migrate to the meninges along olfactory nerves (Sjolinder and Jonsson 2010) . Whether migration to nasal cavity sites occurs through respiratory droplets or bacterial motility is unknown. Regardless of the mechanism, Neisseria can migrate to nasal cavity sites and persist in this model.
The RM Neisseria macaque colonization model recapitulates several aspects of Neisseria-host interactions that are refractory to in vivo experimentation. This system involves infection of RMs with Neisseria species indigenous to the animal. This approach circumvents host restrictions and can allow the dissection of molecular mechanisms of pharyngeal colonization, transmission, long-term persistence and HGT. Since many orthologs of Ngo/Nme virulence factors are encoded by RM Neisseria genomes, we now have tools to study mechanisms of asymptomatic carriage strain transmission, persistence and spread of AMR by HGT.
Human volunteer models
Human volunteer studies have been conducted to study nasopharyngeal colonization by commensal N. lactamica. The Read lab has shown that intranasal inoculation resulted in carriage for at least 24 weeks. Carriers of N. lactamica produce both salivary IgA and serum IgG to N. lactamica (Evans et al. 2011) . The N. lactamica-induced antibodies were opsonophagocytic to Nme. Further work demonstrated that N. lactamica carriage was capable of displacing Nme or impeding subsequent Nme acquisition (Deasy et al. 2015) . This work provides a proof of concept that N. lactamica inoculations could be used to quell Nme outbreaks.
ANTIBIOTICS
Antimicrobial therapy is routinely used to treat uncomplicated urogenital gonorrhea infections. Historically, pharyngeal gonorrhea is more difficult to cure relative to urogenital or rectal infections (Moran 1995) . Treatment failures are more likely (reviewed in Lewis 2015; see also Hutt and Judson 1986) . The pharynx is frequently colonized asymptomatically and can serve as a reservoir for Ngo and Nme persistence and transmission. The pharynx is also a niche where both neisserial pathogens can acquire AMR determinants from commensal species (Spratt et al. 1992; Ito et al. 2005; Wu et al. 2009 ). AMR in commensal Neisseria species likely emerges from repeated exposures to antibiotics. Ideally, if antibiotic therapy could be administered in such a way to minimize emergence of resistance in commensal Neisseria species, there would be less dissemination of AMR by HGT to pathogenic Neisseria species in the pharynx. There is a need to characterize the emergence of AMR resistance that arises in respiratory niches including sites in the nasal cavity such as olfactory epithelial sites, turbinates, nasopharynx, tongue, dental plaque and saliva.
Pharmokinetic and phamacodynamic analyses frequently measure antibiotic concentrations in plasma but not always in the tissues or fluids associated with sites of infection. A better understanding of the selective pressures microbes encounter in niches of the upper respiratory tract during antimicrobial therapies is needed to minimize emergence of AMR. Fantin et al. (2009) assessed how six different ciprofloxacin dosage regimens influenced the rise of AMR in commensal Streptococci of the pharynx in human volunteers. Several parameters were measured including the minimum inhibitory concentration (MIC) and mutant prevention concentration (MPC). Ciprofloxin levels in the pharynx, as measured in saliva, never exceeded the MIC or MPC against Streptococci during the entire treatment period of 14 days. As a result, ciprofloxin resistance emerged during treatment. The study also looked at emergence of ciprofloxacin resistance of Escherichia coli in the fecal flora. Ciprofloxacin treatment regimens exceeded the MIC and MPC of E. coli flora. As a result, emergence of resistance only occurred after treatments ceased when ciprofloxacin levels likely dropped below the MIC and MPC. The authors concluded that emergence of ciprofloxacin resistance is an ecological side effect that cannot be prevented by optimization of antibiotic dosage. This study highlights the need to identify antibiotics that can be transported or concentrated in saliva or other respiratory tract fluids and tissues so the MIC and MPC of commensal flora can be exceeded during treatment. The study by Fantin et al. could be considered discouraging to hopes for future development of treatments that minimize emergence of AMR. However, the study did not characterize if fitness defects were associated with ciprofloxacin-resistance mutations or if the mutations persisted long term in volunteers after cessation of treatment. Moreover, new antibiotics are being found to which bacteria have difficulty developing resistance. One example is lugdunin, an antibiotic efficacious against Staphylococcus aureus. Thirty days of in vitro serial passage at sublethal lugdunin concentrations did not select for resistance (Zipperer et al. 2016) .
Characterizing emergence of resistance in vitro by serial passage in the presence of antibiotics by MPC determination and mutation rate measurements are not sufficient. High in vitro mutation rates do not always predict the rise of AMR in vivo. Conversely, low in vitro mutation rates may not correlate with slow development of resistance in vivo (reviewed in Andersson 2015) . Characterizing fitness defects in vivo will help inform if AMR determinants previously characterized in vitro can expand in vivo and become fixed in the circulating microbiota. Nme penicillin resistance determinants have fitness defects compared to wildtype strains in a lung colonization and sepsis model (Zarantonelli et al. 2013) . The animal models discussed above give us an opportunity to begin accumulating in vivo data on neisserial population sizes and emergence, fitness, persistence and HGT of AMR. Moreover, these models can help researchers gain experience with promising antibiotics in the treatment of neisserial respiratory infections with the aim of minimizing emergence of resistance in commensals of the genus.
Examples of drugs in current development for uncomplicated gonorrhea infections include ETX0914 (DNA gyrase inhibitor), Gepotidacin (GSK2140944; topoisomerase inhibitor) and Solithromycin (macrolide) (Foerster et al. 2015; Riedel et al. 2015; Jones et al. 2016 ). REDX05931, a novel tricyclic topoisomerase inhibitor, has been tested for efficacy in the vaginal mice model and found to have high oral availability (Savage et al. 2016) . Preliminary ETX0914 breakpoints have been determined in a thigh infection model of Staphylococcus aureus (Basarab et al. 2015) . Knowing the breakpoints efficacious against nasopharyngeal carriage of Neisseria species would be invaluable since both Ngo and Nme isolates are emerging with resistance or reduced susceptibility to antibiotics (Ohnishi et al. 2011; Deghmane, Hong and Taha 2017) . Since Neisseria species are very capable of interspecies HGT, new antibiotics should be tested in a wide range of Neisseria species found in the respiratory tract to confirm sensitivity. Upper respiratory tract Neisseria models of colonization will allow the preclinical assessment of whether antibiotics are efficacious against carriage. Such knowledge would be valuable for the development of dosing regimens for the treatment of pharyngeal gonorrhea infections. By trying to replicate human treatment failures in animal models, researchers may be able to develop more effective therapies.
CONCLUSION AND FUTURE DIRECTIONS
Upper respiratory tract neisserial models can be utilized to elucidate the molecular mechanisms that promote infection and persistence. Moreover, they can assess efficacy at eliminating carriage at this site via antimicrobials, vaccines and displacement (probiotics). Correlating what researchers learn from these models with data from infected patients for both treatment failures and successful antimicrobial therapies will certainly help us combat the current threat of AMR. Scientists need more knowledge about the development of AMR in both pathogenic and commensal Neisseria species. Is the widespread overuse of antibiotics for respiratory infections contributing to AMR in commensals that disseminates to Ngo or Nme? There are many additional outstanding questions that neisserial respiratory models may be able to answer. Which Neisseria species in humans and animals manifest host tropism? Such knowledge may help us focus on species that will be more informative in studying determinants of host-bacterial interactions relevant to human disease. What cell types do Neisseria adhere to or invade in the nasal cavity and pharynx? What factors are required for dissemination within a host and transmission to new hosts? Current models focus on nasal washes and swabbing for detection of carriage. As Nme has been shown to inhabit intracellular niches, models may need to be modified to better quantify intracellular bacterial counts (Sim et al. 2000) . A catalog of neisserial loci and proteins essential for life in respiratory tract niches is needed. One report of proteins expressed in the nasal cavity of CD46 mice was recently published (Liu et al. 2016) . The diversity of models being used to study Neisseria species in the upper respiratory tract will hopefully complement one another and lead to the development of vaccines efficacious against carriage and effective antimicrobial therapies.
